Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
Is Puma Biotechnology a Buy? | The Motley Fool
Puma Biotechnology: Nerlynx Peak Sales Estimates Have Come Down, But The Intense Selling Still Makes This A Buy (NASDAQ:PBYI) | Seeking Alpha